开放与腔内左锁骨下动脉血运重建在2区胸主动脉腔内修复术中的比较
基于血管质量倡议2013至2023年2489例择期2区胸主动脉腔内修复术(TEVAR)并左锁骨下动脉(LSA)血运重建患者,比较开放与腔内LSA血运重建。腔内组卒中率低于开放组(2.6% vs 4.8%,aOR 0.50),脊髓缺血、围术期死亡及5年死亡无显著差异;总体院内复合并发症更低。
要点
- 腔内LSA血运重建较开放卒中率更低(2.6% vs 4.8%,aOR 0.50)。
- 两组脊髓缺血、围术期死亡及5年死亡无显著差异。
- 腔内组总体院内复合并发症更低(20% vs 27%,aOR 0.64)。
核心结论
- 在2区TEVAR患者中,腔内LSA血运重建较开放LSA血运重建术后卒中率和总体院内复合并发症更低,但脊髓缺血、围术期死亡和5年死亡率相似。
- 未来需比较研究评估腔内LSA血运重建的中长期安全性及不同腔内技术间的差异。
研究设计与样本
- 基于血管质量倡议(Vascular Quality Initiative)2013至2023年成人TEVAR且近端锚定区为2区并行LSA血运重建的患者。
- 排除创伤性主动脉损伤、主动脉血栓或破裂表现者,按血运重建类型分层为开放(外科旁路或移位)与任何腔内(单分支、开窗或平行支架)两组。
- 共纳入2489例,其中开放组1842例(74%),腔内组647例(26%)。
- 主要结局为卒中、脊髓缺血(SCI)和围术期死亡,采用Pearson χ2检验及多因素logistic回归分析。
- 次要结局包括其他院内并发症和5年死亡率(Kaplan-Meier、多因素Cox回归),并对同期行LSA血运重建者进行敏感性分析。
主要发现
- 腔内组较开放组手术时间更短(中位135分钟 vs 174分钟,P < .001),透视时间更长(中位23分钟 vs 16分钟,P < .001),估计失血量更少(中位100 mL vs 123 mL,P < .001),术前脊髓引流使用更少(40% vs 49%,P < .001)。
- 腔内组较开放组急诊(24% vs 19%)和紧急(7.4% vs 3.4%)就诊比例更高(P < .001)。
- 腔内组较开放组卒中率更低(2.6% vs 4.8%,P = .026;校正OR 0.50,95%CI 0.25-0.90),脊髓缺血(2.9% vs 3.5%,P = .60;校正OR 0.64,95%CI 0.31-1.22)和围术期死亡(3.1% vs 3.3%,P = .94;校正OR 0.71,95%CI 0.34-1.37)无显著差异。
- 腔内组较开放组总体院内复合并发症更低(20% vs 27%,P < .001;校正OR 0.64,95%CI 0.49-0.83),总住院时间更短(7天 vs 8天,P < .001)。
- 校正后5年死亡率两组相似(校正HR 0.85,95%CI 0.64-1.13),敏感性分析支持主要分析结果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In patients undergoing elective thoracic endovascular aortic repair (TEVAR) and left subclavian artery (LSA) coverage, routine preoperative LSA revascularization is recommended. However, in the current endovascular era, the optimal surgical approach is debated. We compared baseline characteristics, procedural details, and perioperative outcomes of patients undergoing open or endovascular LSA revascularization in the setting of TEVAR. METHODS: Adult patients undergoing TEVAR with zone 2 proximal landing and LSA revascularization between 2013 and 2023 were identified in the Vascular Quality Initiative. We excluded patients with traumatic aortic injury, aortic thrombus, or ruptured presentations, and stratified based on revascularization type (open vs any endovascular). Open LSA revascularization included surgical bypass or transposition. Endovascular LSA revascularization included single-branch, fenestration, or parallel stent grafting. Primary outcomes were stroke, spinal cord ischemia (SCI), and perioperative mortality (Pearson's χ2 test). Multivariable logistic regression was used to evaluate associations between revascularization type and primary outcomes. Secondarily, we studied other in-hospital complications and 5-year mortality (Kaplan-Meier, multivariable Cox regression). Sensitivity analyses were performed in patients undergoing concomitant LSA revascularization to TEVAR. RESULTS: Of 2489 patients, 1842 (74%) underwent open and 647 (26%) endovascular LSA revascularization. Demographics and comorbidities were similar between open and endovascular cohorts. Compared with open, endovascular revascularization had shorter procedure times (median, 135 minutes vs 174 minutes; P < .001), longer fluoroscopy times (median, 23 minutes vs 16 minutes; P < .001), lower estimated blood loss (median, 100 mL vs 123 mL; P < .001), and less preoperative spinal drain use (40% vs 49%; P < .001). Patients undergoing endovascular revascularization were more likely to present urgently (24% vs 19%) or emergently (7.4% vs 3.4%) (P < .001). Compared with open, endovascular patients experienced lower stroke rates (2.6% vs 4.8%; P = .026; adjusted odds ratio [aOR], 0.50 [95% confidence interval (CI), 0.25-0.90]), but had comparable SCI (2.9% vs 3.5%; P = .60; aOR, 0.64 [95% CI, 0.31-1.22]) and perioperative mortality (3.1% vs 3.3%; P = .94; aOR, 0.71 [95% CI, 0.34-1.37]). Compared with open, endovascular LSA revascularization had lower rates of overall composite in-hospital complications (20% vs 27%; P < .001; aOR, 0.64 [95% CI, 0.49-0.83]) and shorter overall hospital stay (7 vs 8 days; P < .001). After adjustment, 5-year mortality was similar among groups (adjusted hazard ratio, 0.85; 95% CI, 0.64-1.13). Sensitivity analyses supported the primary analysis with similar outcomes. CONCLUSIONS: In patients undergoing TEVAR starting in zone 2, endovascular LSA revascularization had lower rates of postoperative stroke and overall composite in-hospital complications, but similar SCI, perioperative mortality, and 5-year mortality rates compared with open LSA revascularization. Future comparative studies are needed to evaluate the mid- to long-term safety of endovascular LSA revascularization and assess differences between specific endovascular techniques.
引用
- Mandigers TJ, Allievi S, Jabbour G, et al. Comparison of open and endovascular left subclavian artery revascularization for zone 2 thoracic endovascular aortic repair. J Vasc Surg. 2024. PMID: 38880180. doi:10.1016/j.jvs.2024.06.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。